SCHEMBL4605960

SCHEMBL4605960

CCC(=O)Nc1ccc(COc2ccccc2N2CCN(C)CC2)cc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.47
ALDH1A1 P00352 3/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
MAPK1 P28482 2/20 0.47
HSD17B10 Q99714 2/20 0.47
NPBWR1 P48145 1/20 0.46
MCHR1 Q99705 1/20 0.46
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 2/20 0.42
PKM P14618 1/20 0.42
HTR1A P08908 1/20 0.42
HTR7 P34969 1/20 0.42
DRD2 P14416 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606153 0.91 NPSR1 (0.48) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4605838 0.89 ALDH1A1 (0.52) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4606133 0.85 MEN1 (0.48) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4604606 0.82 NPBWR1 (0.45) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4604092 0.80 ALDH1A1 (0.49) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4606969 0.77 DVL1 (0.56) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4606032 0.77 ALDH1A1 (0.46) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4603742 0.77 KDM4E (0.47) GAAALDH1A1KMT2AMEN1HSD17B10
SCHEMBL4603286 0.77 ALDH1A1 (0.43) GAAALDH1A1TSHRKMT2AMEN1
SCHEMBL4603292 0.77 ALDH1A1 (0.43) GAAALDH1A1TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1914152-B New compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB 2010-06-09 CN disclosed
EP-1720825-B1 ANTHRANILIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USE AS DHODH INHIBITORS ACTIVE BIOTECH AB (SE) 2008-07-09 EP disclosed
CN-1914152-A New compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2007-02-14 CN disclosed
US-7074831-B2 Compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2006-07-11 US disclosed
US-20050187297-A1 New compounds, methods for their preparation and use thereof ACTIVE BIOTECH AB (SE) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187297-A1 New compounds, methods for their preparation and use thereof MALT1, TPMT, FUCA1 GAA 864/4885ALDH1A1 308/4885TSHR 3450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.